Alyeska Investment Group »

Nuvectis Pharma shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Nuvectis Pharma (NVCT) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Nuvectis Pharma

Tip: Access up to 7 years of quarterly data

All positions including Nuvectis Pharma held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvectis Pharma by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.1M 275k 18.39

More positions owned by Alyeska Investment Group

Ishares Tr Core S&p500 Etf (IVV)
Coreweave Com Cl A (CRWV)
Meta Platforms Cl A (META)
salesforce (CRM)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Intuitive Surgical Com New (ISRG)
Amazon (AMZN)
Amphenol Corp Cl A (APH)
Gpgi Com Cl A (GPGI)
Spotify Technology S A SHS (SPOT)
Analog Devices (ADI)
Burlington Stores (BURL)
Zebra Technologies Corporati Cl A (ZBRA)
Merck & Co (MRK)

View all positions for Alyeska Investment Group

Top funds holding Nuvectis Pharma

Tang Capital Management
BlackRock
Soleus Capital Management
Perceptive Advisors
Vanguard Capital Management
Iridian Asset Management
Geode Capital Management
Sphera Funds Management
Baldwin Brothers
Occam Crest Management
Susquehanna International
Alyeska Investment Group
Avidity Partners Management
Citadel Advisors
State Street Corporation

View all funds holding Nuvectis Pharma